Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of Erwinia amylovora and HrpL mutants
The bacterial pathogen Erwinia amylovora is the causal agent of fire blight, an economically significant disease of apple and pear. Disease initiation by E. amylovora requires the translocation of effector proteins into host cells by the hypersensitive response and pathogenicity (hrp) type III secr...
ORGANISM(S): Erwinia amylovora 
2012-03-28 | E-TABM-1137 | biostudies-arrayexpress
GenomicsEGAS00001000814-sc-20150331 - samples
The aim of this study is to ascertain whether leukaemic mutations exist within the blood of people with otherwise normal haematopoeisis. To satisfy this aim we plan to look for 7 known leukaemic mutations in the whole blood DNA of a large cohort of blood donors who have normal haematopoesis. Genom...
EGAD00001001319 | EGA
GenomicsStudy to investigate the prevalence of leukaemic mutations in whole blood DNA in a cohort of blood donors
The aim of this study is to ascertain whether leukaemic mutations exist within the blood of people with otherwise normal haematopoeisis. To satisfy this aim we plan to look for 7 known leukaemic mutations in the whole blood DNA of a large cohort of blood donors who have normal haematopoesis. Genom...
EGAS00001000814 | EGA
UnknownRare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project.
Not available
S-EPMC4673986 | biostudies-literature
UnknownVariation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic.
Not available
S-EPMC10326494 | biostudies-literature
UnknownDiscovery and fine mapping of serum protein loci through transethnic meta-analysis.
Not available
S-EPMC3484648 | biostudies-literature
UnknownWhole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.
Not available
S-EPMC3928660 | biostudies-literature
UnknownViral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
Not available
S-EPMC2745911 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownPrediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595 | biostudies-literature
Sort   by:  
 Page size